Literature DB >> 8450070

Cholesterol kinetics in subjects with bile fistula. Positive relationship between size of the bile acid precursor pool and bile acid synthetic rate.

C C Schwartz1, L A Zech, J M VandenBroek, P S Cooper.   

Abstract

Our aim was to identify and quantitate cholesterol pools and transport pathways in blood and liver. By studying bile fistula subjects, using several types of isotopic preparations, simultaneous labeling of separate cholesterol pools and sampling all components of blood and bile at frequent intervals, we developed a comprehensive multicompartmental model for cholesterol within the rapidly miscible pool. Data in six components (bile acids, esterified cholesterol in whole plasma, and free cholesterol in blood cells, bile, alpha lipoproteins, and beta lipoproteins) were modeled simultaneously with the SAAM program. The analysis revealed extensive exchange of free cholesterol between HDL and liver, blood cells, and other tissues. There was net free cholesterol transport from HDL to the liver in most subjects. The major organ that removed esterified cholesterol from blood was the liver. A large portion (4,211 mumol) of total hepatic cholesterol comprised a pool that turned over rapidly (t1/2 of 72 min) by exchanging mainly with plasma HDL and was the major source of bile acids and biliary cholesterol. Only 6% of hepatic newly synthesized cholesterol was used directly for bile acid synthesis: the analysis showed that 94% of newly synthesized cholesterol was partitioned into the large hepatic pool (putative plasma membrane free cholesterol) which exchanged rapidly with plasma lipoproteins. Bile acid synthetic rate correlated directly with the size of the large hepatic pool. In conclusion, hepatic and blood cholesterol pools and transports have been quantitated. HDL plays a central role in free cholesterol exchange/transport between all tissues and plasma. In humans, the metabolically active pool comprises a large portion of total hepatic cholesterol that, in part, regulates bile acid synthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450070      PMCID: PMC288045          DOI: 10.1172/JCI116314

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man.

Authors:  C C Schwartz; L G Halloran; Z R Vlahcevic; D H Gregory; L Swell
Journal:  Science       Date:  1978-04-07       Impact factor: 47.728

2.  Evidence for a common hepatic cholesterol precursor site for cholic and chenodeoxycholic acid synthesis in man.

Authors:  C C Schwartz; Z R Vlahcevic; L G Halloran; R Nisman; L Swell
Journal:  Proc Soc Exp Biol Med       Date:  1977-11

3.  Parameters of the three-pool model of the turnover of plasma cholesterol in normal and hyperlipidemic humans.

Authors:  F R Smith; R B Dell; R P Noble; D S Goodman
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

4.  Central role of high density lipoprotein in plasma free cholesterol metabolism.

Authors:  C C Schwartz; Z R Vlahcevic; M Berman; J G Meadows; R M Nisman; L Swell
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

5.  Multicompartmental analysis of cholesterol metabolism in man. Characterization of the hepatic bile acid and biliary cholesterol precursor sites.

Authors:  C C Schwartz; M Berman; Z R Vlahcevic; L G Halloran; D H Gregory; L Swell
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

6.  Multicompartmental analysis of cholesterol metabolism in man. Quantitative kinetic evaluation of precursor sources and turnover of high density lipoprotein cholesterol esters.

Authors:  C C Schwartz; M Berman; Z R Vlahcevic; L Swell
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

7.  High density lipoprotein metabolism in man.

Authors:  C B Blum; R I Levy; S Eisenberg; M Hall; R H Goebel; M Berman
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

8.  Analysis of the distribution of cholesterol in the intact cell.

Authors:  Y Lange; B V Ramos
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

9.  Three-pool model of the long-term turnover of plasma cholesterol in man.

Authors:  D S Goodman; R P Noble; R B Dell
Journal:  J Lipid Res       Date:  1973-03       Impact factor: 5.922

10.  The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia.

Authors:  T Langer; W Strober; R I Levy
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

View more
  12 in total

1.  Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women.

Authors:  N R Matthan; M Raeini-Sarjaz; A H Lichtenstein; L M Ausman; P J Jones
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

2.  In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.

Authors:  Adriaan G Holleboom; Lily Jakulj; Remco Franssen; Julie Decaris; Menno Vergeer; Joris Koetsveld; Jayraz Luchoomun; Alexander Glass; Marc K Hellerstein; John J P Kastelein; G Kees Hovingh; Jan Albert Kuivenhoven; Albert K Groen; Scott M Turner; Erik S G Stroes
Journal:  J Lipid Res       Date:  2013-05-06       Impact factor: 5.922

3.  Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I.

Authors:  M Ikemoto; H Arai; D Feng; K Tanaka; J Aoki; N Dohmae; K Takio; H Adachi; M Tsujimoto; K Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  The effects of short term lipid infusion on plasma and hepatic bile lipids in humans.

Authors:  R Pakula; F M Konikoff; A M Moser; F Greif; A Tietz; T Gilat; M Rubin
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

5.  Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice.

Authors:  Seth G Thacker; Xavier Rousset; Safiya Esmail; Abdalrahman Zarzour; Xueting Jin; Heidi L Collins; Maureen Sampson; John Stonik; Stephen Demosky; Daniela A Malide; Lita Freeman; Boris L Vaisman; Howard S Kruth; Steven J Adelman; Alan T Remaley
Journal:  J Lipid Res       Date:  2015-05-11       Impact factor: 5.922

6.  Homeostasis of free cholesterol in the blood: a preliminary evaluation and modeling of its passive transport.

Authors:  Luís M B B Estronca; Hugo A L Filipe; Armindo Salvador; Maria João Moreno; Winchil L C Vaz
Journal:  J Lipid Res       Date:  2014-04-07       Impact factor: 5.922

7.  Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin.

Authors:  Raul D Santos; Ana P M Chacra; Aleksandra Morikawa; Carmen C Vinagre; Raul C Maranhão
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

8.  A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans.

Authors:  Marina Cuchel; Anna C Raper; Donna M Conlon; Daniel A Pryma; Richard H Freifelder; Rahul Poria; Debra Cromley; Xiaoyu Li; Richard L Dunbar; Benjamin French; Liming Qu; William Farver; Ching-Chiang Su; Sissel Lund-Katz; Amanda Baer; Giacomo Ruotolo; Peter Akerblad; Carol S Ryan; Lan Xiao; Todd G Kirchgessner; John S Millar; Jeffrey T Billheimer; Daniel J Rader
Journal:  J Lipid Res       Date:  2017-02-06       Impact factor: 5.922

Review 9.  Inhibition of cholesteryl ester transfer protein activity: a new therapeutic approach to raising high-density lipoprotein.

Authors:  Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

10.  Characterization of placental cholesterol transport: ABCA1 is a potential target for in utero therapy of Smith-Lemli-Opitz syndrome.

Authors:  Marie L Lindegaard; Christopher A Wassif; Boris Vaisman; Marcelo Amar; Elizabeth V Wasmuth; Robert Shamburek; Lars B Nielsen; Alan T Remaley; Forbes D Porter
Journal:  Hum Mol Genet       Date:  2008-09-05       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.